Navigation Links
Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer
Date:9/3/2014

of Physicians.

Notes to editors 

About Nabriva Therapeutics AG  

Nabriva Therapeutics is a biotechnology company focused on developing a new class of antibiotics, the pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resistant pathogens. Nabriva's world-class medicinal chemistry expertise has achieved an industry first with the development of both intravenously administered and orally available pleuromutilins that are therefore ideal for i.v. to oral switch therapy.

Nabriva's lead product lefamulin (BC‑3781) is about to enter Phase 3 clinical studies. Due to its broad spectrum, oral and i.v. formulations, and a favourable safety profile, lefamulin is the first of a new class of antibiotics ideally positioned for the treatment of community-acquired bacterial pneumonia (CABP), plus hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP), as well as acute bacterial skin and skin structure infections (ABSSSI), with potential in several other indications (sexually transmitted infections including MDR gonorrhoea; osteomyelitis) including paediatric use.

Nabriva's preclinical program, the Extended Spectrum Pleuromutilins (ESPs) expands the activity of pleuromutilins to include major enteric Gram-negative pathogens such as E. coli and K. pneumoniae. The targeted indications for the ESP extend beyond the current use of the first-generation pleuromutilins, thereby filling important gaps in treatment options of both marketed antibiotics and compounds in development.

For further information, please contact: 

Nabriva Therapeutics AG
Dr Colin Broom, Chief Executive Officer
Tel: +43(0)1-740-930
Email: office@nabriva.com

Hume Brophy
Mary Clark, Supriya Mathur, Holli
'/>"/>

SOURCE Nabriva Therapeutics AG
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Legislation passed today by the House Ways ... prevent inappropriate prescriptions in Medicare Part D from crossing ... Medicare Act (PIMA) of 2014 , introduced by Ways ... (R-TX) and Ranking Member Jim McDermott (D-WA), recognizes the ... implement the right policies, said the Pharmaceutical Care Management ...
(Date:2/26/2015)... Feb. 26, 2015  Spring Bank Pharmaceuticals, Inc., ... the treatment of Hepatitis B virus (HBV) and ... a $22 million financing. Funds from this financing ... novel, broad spectrum antiviral agent derived from ... (SMNH) chemistry platform, into Phase II clinical trials ...
(Date:2/26/2015)... , Feb. 26, 2015 The ... America is estimated at 2.4 billion ... that population growth, government insurance, newly insured patients ... the region and will continue to propel demand.  The ... torresearch into the market and interviews with IVD ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 3Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 4
... October 12, 2011 Aircraft Medical ("Aircraft"), ... has signed an exclusive agreement with Covidien (NYSE: ... products with 2010 revenue of $10.4 billion, and 41,000 ... agreement, Covidien will market and distribute Aircraft,s proprietary McGRATH ...
... October 12, 2011 OctreoPharm Sciences ... today that the European Medicines Agency has granted ... for the diagnosis of gastro-entero-pancreatic neuroendocrine tumours. ... to ten year market exclusivity in Europe following ...
Cached Medicine Technology:Aircraft Medical Signs Multinational Distribution Agreement with Covidien for McGRATH® MAC Video Laryngoscope 2OctreoPharm Sciences Receives Orphan Drug Designation for SOMscan® for the Diagnosis of Neuroendocrine Tumours 2
(Date:2/27/2015)... 2015 Qualis Health, one of ... been named a finalist in the 6th Annual ... outstanding commitment toward continuous improvement in care transitions. ... hospital readmission rates through its Communities for Safer ... to receive this national recognition, which demonstrates Qualis ...
(Date:2/27/2015)... 27, 2015 A fireplace can cause the ... its heat through the chimney’s flue when the fireplace is ... Tamarack Technologies has solved with the introduction of a new ... PVC pillow measuring 18" in diameter when inflated. It is ... just below the damper. This size unit fits into round ...
(Date:2/27/2015)... The Connecticut Community for Addiction Recovery (CCAR) recently ... Drug Recovery Centers (ADRC), for its shared Recovery Oriented ... with the 2014 Commissioner’s Recognition Award by the CT ... Last year, ROES achieved the highest rate of employment ... from alcoholism and other drug addiction. More than ...
(Date:2/27/2015)... Lewis Clinic Dentistry has extended its business hours to ... services available for patients who cannot make regular weekday appointments. ... Dentistry said, “Yes, we have extended our business hours so ... their busy schedules and work can come on the weekends. ... lives beautiful and smiling.” He further added, “We are working ...
(Date:2/27/2015)... 27, 2015 Plugin creators from Pixel Film ... Final Cut Pro X. , “TransFold Volume 3 gives users ... FCPX users.” Said Christina Austin, CEO of Pixel Film ... Cut Pro X editor.” , TransFold Volume 3 comes packed ... The user can decide to change the shadow distance, opacity, ...
Breaking Medicine News(10 mins):Health News:Qualis Health Named Award Finalist for Care Transitions Work 2Health News:New DraftStopper from Tamarack Technologies Stops Heat Loss When Fireplace Not in Use 2Health News:Lewis Clinic Dentistry Extends Business Hours 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2
... complication after bypass surgery", say researchers who recently carried ... bypass heart surgery. Pleural effusion involves the accumulation of ... space is //the narrow space between the lungs and ... called the pleura. ,The study indicated that ...
... received approval from the Food and Drug Administration to ... used to relieve post-operative pain in dogs. This drug ... //is the result of a development project undertaken by ... at veterinary clinics, colleges and its manufacturing facilities., ...
... back to school is the attack of acne on their ... is one of the main causes for an attack of ... androgen //which results in an increased production of acne-causing oil. ... the hormonal changes that are already underway. Pimples occur when ...
... month can minimise the risk of ischemic stroke in men according ... developed stroke over a period of 13 years in the ... 76. Ischemic stroke// which is caused by a clot that blocks ... 378 participants, 105 were confirmed as hemorrhagic stroke, caused by a ...
... study, women who drink four cups of coffee per day ... do not drink coffee. Previous studies// on men have shown ... affected with gallstones than men, and those women who are ... risk. ,80,900 women were tracked over a period of ...
... at the Medical college of Wisconsin have recently shown that ... throat area. A one-way valve keeps stomach acid from flowing ... pharyngoglottal closure reflex, which closes off the vocal chords if ... ,Ten smokers and ten non-smokers were tested by imaging ...
Cached Medicine News:
... is a quality control material that, once ... of blood gas, electrolyte, metabolite, and CO-Oximeter ... the use of human blood in tonometry. ... levels for monitoring analyzer performance at varying ...
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens....
... 525 is an assayed quality control ... of blood gas, electrolyte, metabolite, and ... this control makes it the ideal ... It is available in three (3) ...
... to capture and process ultrasound images, Zone ... revolutionary advancement. The z.one platform, powered by ... Ultrasound system, instantly converting from a full-featured ... system with all the performance of substantially ...
Medicine Products: